HIV-1前病毒储存库中非核苷类逆转录酶抑制剂耐药相关突变的动力学
该单中心回顾性研究纳入79例有病毒学失败史且曾检出NNRTI耐药相关突变的法国HIV感染者,在病毒学抑制多年后以NGS检测前病毒DNA。39%患者NNRTI耐药突变未检出,其持续存在与更高前病毒DNA载量及病毒学失败时更高HIV-1 RNA水平相关;突变病毒载量随时间呈下降趋势。
要点
- 病毒学抑制中位10年后,39%患者前病毒DNA中未检出NNRTI耐药突变。
- NNRTI耐药突变持续存在与更高前病毒DNA载量及失败时更高HIV-1 RNA相关。
- 与其他突变不同,NNRTI耐药突变倾向在HIV-1 DNA储存库中持续存在,但部分可清除。
核心结论
- 与M184V和INSTI耐药突变不同,NNRTI耐药相关突变倾向于在HIV-1 DNA储存库中持续存在。
- 部分患者的前病毒储存库中可清除这些存档突变,尤其在前病毒DNA载量低、病毒复制持续时间短及使用失败NNRTI方案时HIV RNA水平低者。
研究设计与样本
- 单中心回顾性研究,纳入79例18岁以上法国HIV感染者,均有含NNRTI方案病毒学失败史且失败时Sanger测序检出至少1个NNRTI耐药相关突变。
- 对至少1份全血样本行靶向逆转录酶基因的下一代测序并结合前病毒DNA定量,样本采集于换用其他方案病毒学抑制多年后。
- 采用多因素分析识别与NNRTI耐药相关突变持续存在相关的因素。
主要发现
- 样本采集于病毒学抑制中位10年及病毒学失败后16年。
- 39%患者的前病毒DNA中未检出NNRTI耐药相关突变。
- NNRTI耐药相关突变的持续存在与更高前病毒DNA载量及病毒学失败时更高HIV-1 RNA水平相关。
- 在62例间隔3年采集两份样本者中,突变病毒载量随时间呈下降趋势。
临床怎么用
- 对有NNRTI病毒学失败史者,评估前病毒DNA中存档耐药突变时应考虑其可随时间清除,尤其前病毒DNA载量低者。
- 前病毒DNA载量高及失败时HIV-1 RNA水平高者,NNRTI耐药突变持续存在的可能性更高。
局限性
- 单中心回顾性设计,样本量有限。
- 原文未报告耐药突变持久性的具体比例、置信区间及多因素分析的效应值。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: In the blood mononuclear cells of persons with HIV (PWHs) with a history of virological failure (VF), some viral strains, archived as proviral DNA, can harbor mutations conferring resistance to antiretrovirals. METHODS: This single-center, retrospective study included French PWHs older than 18 years with a history of VF on a non-nucleoside reverse transcriptase inhibitor (NNRTI)-containing regimen and at least one NNRTI resistance-associated mutation (RAM) detected by Sanger sequencing at the time of VF. Next-generation sequencing targeting the reverse transcriptase gene, in combination with proviral DNA quantification, was performed on at least one whole blood sample after years of virological suppression on other antiretroviral regimens. Multivariate analysis identified factors associated with NNRTI RAM persistence. RESULTS: In total, 79 PWHs were included. Samples were collected after a median of 10 years of virological suppression and 16 years after VF. Non-nucleoside reverse transcriptase inhibitor RAMs were not detected in the DNA in 39% of patients, and persistence was associated with a higher proviral DNA load and a higher HIV-1 RNA level at the time of VF. The mutational viral load tended to decrease over time (as assessed in 62 people with two samples collected at 3-year intervals). CONCLUSIONS: In contrast to other mutations such as M184V and INSTI RAMs, NNRTI RAMs tended to persist within the HIV-1 DNA reservoir. However, clearance of these archived mutations from the cellular reservoir was observed in some cases (low proviral DNA load, short duration of viral replication, and low HIV RNA level while taking failing NNRTIs).
引用
- Drumel T, Sourice J, Allavena C, et al. Kinetics of Non-nucleoside Reverse Transcriptase Inhibitor Resistance-associated Mutations in HIV-1 Proviral Cellular Reservoirs in Non-nucleoside Reverse Transcriptase Inhibitor-experienced Persons. Clin Infect Dis. 2026. PMID: 40757503. doi:10.1093/cid/ciaf430
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。